Skip to main content
Avicanna Inc. logo

Avicanna Inc. — Investor Relations & Filings

Ticker · AVCN ISIN · CA05368K1003 LEI · 254900AUQ4URGWO3FN90 TSX Manufacturing
Open in API
Filings indexed 484 across all filing types
Latest filing 2020-04-16 Regulatory Filings
Country CA Canada
Listing TSX AVCN

About Avicanna Inc.

https://www.avicanna.com/

Avicanna is a commercial-stage international biopharmaceutical company focused on the advancement and commercialization of evidence-based, cannabinoid-based products for the global medical and pharmaceutical markets. The company operates through four commercial pillars: Medical Cannabis Products (RHO Phyto™), a Medical Cannabis Care Platform (MyMedi.ca), a Pharmaceutical Pipeline, and Active Pharmaceutical Ingredients (Aureus Santa Marta™). Avicanna leverages an industry-leading scientific platform, including R&D collaborations with academic institutions and a robust IP portfolio, resulting in over 50 proprietary commercialized SKUs.

Recent filings

Filing Released Lang Actions
Audited annual financial statements – English.pdf
Regulatory Filings
2020-04-16 English
News release - English.pdf
Regulatory Filings
2020-03-30 English
News release - English.pdf
Regulatory Filings
2020-02-24 English
News release - English.pdf
Environmental & Social Information Classification · 95% confidence The document is a press release announcing Avicanna's ranking in the SAM Corporate Sustainability Assessment (CSA) by S&P Global. It focuses on the company's sustainability performance and corporate governance in the cannabis sector. There are no financial statements, regulatory filings, or detailed financial data presented. The document is relatively short (3952 characters) and serves as an announcement rather than a detailed report. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is primarily about environmental and social performance, specifically sustainability assessment results. Therefore, the most appropriate classification is Environmental & Social Information (SR).
2020-02-06 English
Material change report - English.pdf
Capital/Financing Update Classification · 100% confidence The document is a FORM 51-102F3 Material Change Report filed by Avicenna Inc. It announces a material change related to a private placement financing, including details of the offering, tranche closure, and proceeds. The document includes a news release describing the private placement and its terms. The content focuses on a financing event and capital raising activity, not on full financial statements or annual/interim reports. The document length is 6435 characters, which is sufficient to contain substantive information about the financing event. Therefore, this document fits the category of Capital/Financing Update (CAP).
2020-02-03 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the closing of the first tranche of a private placement financing by Avicanna Inc. It details the number of units issued, pricing, use of proceeds, and conditions of the offering. There is no financial statement, audit information, or detailed financial report included. The content focuses on capital raising activities and financing updates. Therefore, this document fits the category of Capital/Financing Update (CAP). The document length is about 4938 characters, which is sufficient for a full announcement rather than a brief note or a report publication announcement. Hence, the classification is CAP with high confidence.
2020-01-25 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.